This article is more than 5 years old. Information may no longer be current.
Top four aesthetics stories of the week
Click Here to Manage Email Alerts
New advances in breast implant tissue expanders are on the horizon, as AirXpanders Inc. announced the primary endpoint was met in its carbon dioxide based tissue expander trial.
Among women undergoing a tissue expander or implant exchange procedure, biofilms may contribute to a proportion of capsular contracture cases, but not all, according to researchers.
Continue reading for two additional stories from the week.
AirXpanders trial meets primary endpoint for breast reconstruction
AirXpanders Inc. announced its XPAND trial has met its primary endpoint in patients undergoing a mastectomy, with its AeroForm tissue expander leading to a successful exchange to a permanent implant with the same safety profile as saline tissue expanders. Read more
Causative relationship between biofilm formation and capsular contracture is difficult to prove
Researchers suggest that bacterial biofilms likely contribute to a proportion of capsular contractures, but not all, among women undergoing a tissue expander/implant exchange procedure. Read more
Most popular aesthetics stories so far this year
It is hard for us to believe but Healio.com/Aesthetics launched only 7 months ago, during the bustling American Academy of Cosmetic Surgery Annual Meeting in New Orleans. Read more
3-D printing could positively affect millions of lives if harnessed correctly
As the cost of 3-D printing decreases, the impact on surgical care could be massive, resulting in a higher quality of health care worldwide. Read more